Extracellular vesicles derived from umbilical cord mesenchymal stem cells Therapy(Vinmec Research Institute Of Stem Cell And Gene Technology)

N/A

Report date: 2026/03/17 20:00:15

Base Information

Drug NameExtracellular vesicles derived from umbilical cord mesenchymal stem cells Therapy(Vinmec Research Institute Of Stem Cell And Gene Technology)

Drug Alias NameVinEV-3UC-MSC-EVs

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyBiologics > Extracellular Vesicles

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsLiver Cirrhosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryVietnam

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesVinmec Research Institute Of Stem Cell And Gene Technology

China Registration ClassN/A

Develop Information

Active CompaniesVinmec Research Institute Of Stem Cell And Gene Technology

Inactive CompaniesN/A

Active IndicationsLiver Cirrhosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A